News

Phreesia (NYSE:PHR) Posts Better-Than-Expected Sales In Q4 But Stock Drops

Healthcare technology company Phreesia (NYSE:PHR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 15.4% year on year to $109.7 million. The company expects the full year’s revenue to be around $477 million, close to analysts’ estimates. Its GAAP loss of $0.11 per share was 35% above analysts’ consensus estimates.

BeautyHealth (NASDAQ:SKIN) Beats Q4 Sales Targets But Full-Year Sales Guidance Misses Expectations Significantly

Skincare company BeautyHealth (NASDAQ:SKIN) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales fell by 13.7% year on year to $83.5 million. On the other hand, next quarter’s revenue guidance of $63.5 million was less impressive, coming in 16.6% below analysts’ estimates. Its GAAP loss of $0.08 per share was 30% above analysts’ consensus estimates.

UiPath (NYSE:PATH) Posts Q4 Sales In Line With Estimates But Stock Drops 17.4%

Automation software company UiPath (NYSE:PATH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.5% year on year to $423.6 million. On the other hand, next quarter’s revenue guidance of $332.5 million was less impressive, coming in 10% below analysts’ estimates. Its non-GAAP profit of $0.26 per share was 34.1% above analysts’ consensus estimates.

US oil executives to meet with Trump next week

U.S. oil producers will meet with President Donald Trump next week, leading industry group the American Petroleum Institute said on Wednesday. Among the topics for discussion are tariffs, trade and exports of liquefied natural gas, an industry source told Reuters. The API, which counts oil majors ExxonMobil and Chevron as members, helped put together the meeting.

SentinelOne (NYSE:S) Exceeds Q4 Expectations But Stock Drops 15%

Cyber security company SentinelOne (NYSE:S) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 29.5% year on year to $225.5 million. On the other hand, next quarter’s revenue guidance of $228 million was less impressive, coming in 3.3% below analysts’ estimates. Its non-GAAP profit of $0.04 per share was $0.03 above analysts’ consensus estimates.

US Bonds Slip as Tariff Worries Overshadow Cooler Inflation Data

(Bloomberg) -- Treasuries fell in a volatile trading session as a recovery in risk sentiment amid the deepening global trade war overshadowed a cooler-than-expected US inflation report.Most Read from BloombergTrump DEI Purge Hits Affordable Housing GroupsNYC Congestion Pricing Toll Gains Support Among City ResidentsElectric Construction Equipment Promises a Quiet RevolutionOpen Philanthropy Launches $120 Million Fund To Support YIMBY ReformsProspect Medical’s Pennsylvania Hospitals at Risk of Cl

Calavo (NASDAQ:CVGW) Misses Q4 Sales Targets

Fresh produce company Calavo Growers (NASDAQ:CVGW) fell short of the market’s revenue expectations in Q4 CY2024, but sales rose 21% year on year to $154.4 million. Its non-GAAP profit of $0.33 per share was 13.8% above analysts’ consensus estimates.